Personal vs Commercial vs Exclusive Screenplay License Guide

Three people can buy the same screenplay and walk away with three completely different things. That gap is the entire subject of personal vs commercial vs exclusive screenplay license, and it is the most common place where a first time producer, a film student, and a writer selling online talk past each other. One buyer gets a watermarked PDF to study. One gets permission to shoot. One gets the script pulled off the market for everyone else. Same document, three legal outcomes, three price points that are not remotely close to one another.

What follows is what separates the tiers, what each one actually obligates the other side to do, and where the traditional option deal sits alongside all of it.

What 'License' Actually Means When You Buy or Sell a Screenplay

A license is permission, not ownership. That distinction is doing more work than most people buying a script realize.

Under U.S. copyright law, the writer owns the copyright in a screenplay the moment it is fixed in tangible form. Nobody has to file anything for that to be true. Critically, a commissioning party does not automatically own a freelance writer's screenplay just because money changed hands. Paying for a script and owning a script are separate events, and only a specific kind of paperwork bridges them.

The narrow exception is work made for hire. A commissioned screenplay only becomes work for hire when two conditions are both satisfied: the parties sign a written agreement expressly stating the work is made for hire, and the work falls into one of a closed list of statutory categories. A contribution to a motion picture or other audiovisual work is on that list, so a screenplay can qualify. Those two conditions are what the Copyright Office states. The widely repeated rule that the agreement must be signed before any pages exist comes from case law rather than the statute, and the circuits have not read it identically, so sign first rather than relying on fixing it later. Outside those statutory categories an indep and outside those statutory categories an independent contractor's work cannot become work for hire no matter what the contract says. That treatment is reserved for actual employees working within the scope of employment.

So unless a valid work for hire agreement or an outright assignment is in play, the writer keeps the copyright and everything else is a carve out from the bundle of rights that copyright contains. A license defines the size of the carve out: what you may do with the pages, for how long, and whether anyone else is allowed to do the same thing at the same time. Every tier below is a different answer to those three questions.

Personal vs Commercial vs Exclusive Screenplay License: The Three Tiers Compared

The three tier structure exists because the three buyer types are genuinely different people with genuinely different needs.

The personal, or reader, license is for someone who wants to read the script. Students, aspiring writers, actors studying a role, development readers, anyone building a sense of what working pages look like on the page rather than on screen. It grants reading and personal study. It grants nothing else.

The commercial, or production, license is for someone who wants to shoot the thing. It is typically non exclusive when sold through a self serve platform, meaning the writer can license the same screenplay to another producer while your license is live.

The exclusive license is for someone who wants the script and wants nobody else to have it. It is the tier that removes the screenplay from the market.

The pricing gap between them is the fastest way to understand that these are not three sizes of the same product. Concrete public figures are hard to come by. No platform we can check publishes a comparable public price list for production or exclusive tiers, and ScriptLix itself publishes only its reading prices, with the Reader Edition at $6.99 and subscriptions from $9.99 a month. Commentary puts non exclusive production licences in the high hundreds to low thousands and exclusive sales for emerging writers in the mid four to low five figures, but no primary dated source supports a specific figure, so treat any confident number as an opening position rather than a market rate.

What that spread tells you is that price tracks what the buyer is allowed to do, not the length or quality of the document. The same screenplay can be a $6.99 transaction or a five figure one. The words are identical. The permission is not.

The Personal (Reader) License: What It Lets You Do and What It Doesn't

This is the tier with the clearest terms, and the one most frequently misread.

ScriptLix's Terms of Service describe the self serve purchase as Reader Access, granting "a personal, non-commercial, non-transferable right to read the purchased screenplay and download authenticated PDF, TXT, and Fountain exports for personal study." The same document states the buyer "may not redistribute, sublicense, resell, or commercially exploit the screenplay," and then removes the ambiguity entirely: "Purchasing a screenplay does not convey production, distribution, adaptation, exclusive, or ownership rights of any kind."

That is a fair template for what a reader tier is across the category. You get the full text, not just the sample. You get file formats you can actually work in. On ScriptLix specifically the Reader Edition runs $6.99, covers the complete screenplay in PDF, TXT, and Fountain, carries permanent access with no expiry and no subscription, and ships with strong visible purchaser watermarking. The watermark is the enforcement mechanism: a leaked file points back at whoever bought it.

Refund terms on this tier tend to be shaped by the fact that a script can be consumed in one sitting. ScriptLix offers a full refund within 14 days of a Reader Access purchase, but only if the buyer has read less than 25% of the script. Past that point the content is considered consumed and is no longer eligible. That threshold is worth reading before you skim four acts and change your mind.

The practical use case is study and evaluation. If you are a producer deciding whether a script is worth a real conversation, the reader tier is the correct and cheap first step. It is not a rights position, and it will not survive contact with anyone who checks.

The next tier is where the conversation stops being a checkout flow and starts being a negotiation, because the thing being sold is no longer a file. It is permission to spend other people's money turning that file into a production.

The Commercial (Production) License: Non-Exclusive Rights to Shoot the Thing

A production license is the first tier where the buyer is allowed to make something. It grants the right to produce the screenplay, and on a self serve platform it is typically non exclusive, which is the word that carries all the risk.

Non exclusive means the writer retains the right to license the same script again. Another producer, in another city, with another budget, can be shooting the same pages on a parallel timeline. For a short film, a proof of concept, or a festival piece, that may be perfectly acceptable. For anything with real financing behind it, it usually is not, because a distributor evaluating your film wants to know that yours is the only version of it.

This split is visible in how self serve platforms are actually structured: marketplaces like ScriptLix sell a low cost reader or study license at checkout and route production, option, and exclusivity arrangements into direct negotiation instead, on the reasoning that the terms a producer needs cannot be reduced to a button. ScriptLix's own How It Works page puts it bluntly: "Reading a script is not the same as being allowed to shoot it."

One caution before you treat non exclusive production licensing as a standard industry instrument. It is a self serve marketplace mechanism. The traditional side of the business, meaning agencies, studios, and WGA signatory producers, does not transact this way. That world runs on option agreements, shopping agreements, and outright purchase agreements. The two frameworks coexist but they are not the same market, and describing a non exclusive production license as normal industry practice outside of self serve platforms would be wrong.

The indicative price band for this tier, again from a single operator's estimate rather than a cross market survey, sits around $300 to $1,500. Set against the cost of actually mounting a production, that is a small line item, which is part of why writers push toward exclusivity when they can.

That asymmetry is exactly why the exclusive tier exists, and why it is priced as a different category of event rather than a bigger version of the same purchase.

The Exclusive License: Full Rights Transfer and What Disappears From the Market

An exclusive deal is the tier where the listing comes down. The writer stops being able to sell the script to anyone else, and the buyer stops competing with hypothetical parallel productions.

The phrase that recurs in marketplace contract language is a full transfer of commercial rights to the screenplay going forward. Read that carefully, because it is contract language, not a copyright law term of art. A full transfer of commercial rights is not automatically the same thing as a formal copyright assignment, which carries its own recordation mechanics at the U.S. Copyright Office, and it is not the same thing as a work for hire buyout, which as covered above has a hard timing requirement that a post delivery contract cannot satisfy. If your financing or your distributor is going to need copyright level certainty rather than contractual exclusivity, that is a question for counsel, before the wire, not after.

For the writer, exclusivity is a real decision rather than a payday. The script stops earning from every other channel. A screenplay that could have been licensed non exclusively to four different short film producers over three years earns once instead. The indicative band for an exclusive marketplace sale by an emerging writer, from that same single operator estimate, is roughly $5,000 to $20,000. Whether that clears the opportunity cost depends entirely on how much traction the script actually had.

For the buyer, exclusivity buys the ability to raise money without a footnote. It is very difficult to attach talent, close financing, or sign a distribution agreement while explaining that another producer holds an identical right to the same material.

Once you understand the tiers as three different permissions rather than three price points, the practical question becomes much easier to answer, because it stops being about budget and starts being about what your project has to survive.

Personal vs Commercial vs Exclusive Screenplay License: Which One a Producer Actually Needs

Start with the destination, not the purchase. What the finished film needs to do determines which tier is sufficient.

If the project is a study exercise, a table read, an acting reel, or an internal evaluation, the reader tier is correct and everything above it is wasted money. If the project is a short film with no commercial distribution ambition, a non exclusive production license may genuinely be enough. If the project is a feature intended for distribution, festivals with acquisition potential, or any form of sale, exclusivity or an option toward purchase is effectively mandatory, because the downstream requirements covered later in this article will not accept anything softer.

The honest failure mode is a producer who buys a reader license, spends eighteen months and real money in development, and discovers at the insurance stage that they never held the right to make the film at all. There is no retroactive fix that does not involve going back to the writer with weak leverage.

It is also worth calibrating against what the unionized side of the business pays, so marketplace numbers are read in context. The WGA's own Screen Compensation Guide, drawn from nearly 800 high budget screen deals made during the term of the 2023 Minimum Basic Agreement, reports one step first draft medians of $300,000 for writers with no prior screen credit, $400,000 with one credit, and $600,000 with two or more. Across all companies the median guaranteed compensation on those deals was $450,000, rising to $500,000 at major studios and streamers. That is historical deal data from before May 2026, not a current rate card, and it describes a completely different transaction from a marketplace license. It is useful only as a reminder of the scale difference between the two markets.

If the answer to the tier question is anything above reader access, you are no longer buying a product. You are entering a negotiation, and the standard instrument for that negotiation predates every marketplace by decades.

Option Agreements, Shopping Agreements, and Where They Fit Next to a Marketplace License

An option agreement is the traditional mechanism for exactly the problem a production license tries to solve at checkout: a producer needs control of a screenplay long enough to raise money, but cannot justify buying it outright before the money exists.

An option gives the producer a time limited, typically exclusive right to acquire the screenplay later. Convention puts the option period at commonly 6 to 18 months, with 12 months as a frequent default, often with a negotiated extension. During that window the writer cannot sell elsewhere, and the producer can attach talent and approach financiers with a defensible claim to the material.

The 10% figure gets quoted as though it were universal, and it is not. For WGA covered deals it is firm: the guild stipulates an option price of no less than 10% of the purchase price, satisfying WGA minima. Outside union covered deals the sources genuinely disagree: some put the convention as low as 1% to 3% of the purchase price, while Final Draft, Stage 32 and two entertainment attorneys all describe 10% as the working norm. Know which of the two regimes you are in, and treat the non union number as negotiated rather than standard. It should be read as union rule in one case and soft convention in the other, rather than a universal legal requirement.

A shopping agreement is a different animal and gets confused with an option constantly. It grants a producer the exclusive right to pitch the project to buyers without purchasing it, typically with little or no upfront payment to the writer, for a period commonly described as 6 to 12 months. The practical difference is the one every writer should weigh first: an option puts money in the writer's hands upfront and gives the producer real skin in the game, while a shopping agreement pays nothing unless a sale actually results. A producer with nothing at risk is a producer whose attention can quietly move elsewhere.

This is also where the long odds of the traditional path matter. Trade press tallies of spec script sales have swung enormously across decades: roughly 173 in 1995, 92 in 2000, around 100 per year from 2011 through 2013 (110, 99 and 100), and an average nearer 30 per year in more recent counts, with 25 reported in 2020. Those are press tallies rather than a single authoritative registry, so read them as approximate. The direction is the point. Marketplace tiers exist in part because that funnel is narrow and slow.

Whichever instrument you use, the license or the option is only one document. It is the first page of a file that has to be complete before anyone will insure or distribute the finished film.

Chain of Title, Copyright, and the Paperwork Nobody Budgets For

Chain of title is the paper trail proving legal ownership of every right needed to make and distribute a film. It includes the original screenplay option or purchase agreement, any underlying rights agreements, assignment agreements, and copyright registration certificates.

It is not optional and it is not a formality. Errors and Omissions insurance underwriters require a complete chain of title review before they will quote or issue a policy, and any gap found has to be corrected before coverage begins. Distributors independently require proof of chain of title and E&O coverage, and require the filmmaker to warrant that all necessary rights are properly held. So a marketplace license, at any tier, is necessary but not sufficient. It is one document in a file that must close cleanly, and gaps are always cheaper to fix before a director has been hired.

Two registration items are worth getting right because they are routinely confused with each other.

Copyright registration happens at the U.S. Copyright Office. The electronic filing fee for a Single Application, meaning one author, one claimant, and a work not made for hire, is $45, while the standard electronic Basic Claim registration is $65. That certificate is the document that shows up in a chain of title file.

WGA registration is something else entirely. WGA West's script registry charges $20 for the general public and $10 for WGA members in good standing, and registration is valid for a five year term, renewable for additional five year terms at the then current rate. It is a dated deposit service that evidences when a version of your material existed. It is not a copyright registration and it does not substitute for one.

One timing note that trips up anyone quoting figures right now: the Minimum Basic Agreement that governed WGA minimums since 2023 expired May 1, 2026. Members ratified a new MBA on April 24, 2026, with 90.38% in favor, running May 2, 2026 through May 1, 2030. Under it, most minimums rise 1.5% in year one, then 3% on May 2 in each of 2027, 2028, and 2029. A concrete current figure: the minimum for a page one rewrite, meaning replacing all or substantially all of an existing screenplay, is $57,500 for a high budget feature and $31,500 for a low budget feature for contracts entered into between May 2, 2026 and May 1, 2027. That is a rewrite minimum and should never be quoted as the minimum for an original spec screenplay sale. If someone cites a specific current WGA minimum for an original screenplay, check the schedule it came from, because most figures still circulating belong to the expired 2023 terms.

The whole subject reduces to a habit rather than a rulebook. Before money moves, write down what the buyer is allowed to do, for how long, and whether anyone else can do it at the same time. If the license terms cannot answer those three questions in plain language, the tier is unclear, and an unclear tier is the thing that surfaces eighteen months later at the insurance stage, when it is expensive.

Comparison shopping is easy enough on the access side: InkTip, for example, publishes a Pro membership at $32.50 per month, a standalone script listing tier at $19.99 per month, and additional listings at $12.50 per month, with industry professionals registering free but vetted before they can read scripts. What no platform can standardize for you is the rights layer. That part is still a conversation, still a document, and still the part worth reading twice.